NUVA

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Nuvasive Inc

NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400-person workforce in more than 40 countries serving surgeons, hospitals and patients.
CEO
J. Christopher Barry
Employees
2700
Headquarters

7475 Lusk Blvd
San Diego, California 92121-5707
Phone: 18589091800
www.nuvasive.com

News

NuVasive to Participate in Piper Sandler 34th Annual Healthcare Conference
Nov 16, 2022 12:00pm

SAN DIEGO, Nov. 16, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate…


Source:PR Newswire
NuVasive PT Lowered to $58 at RBC Capital
Nov 10, 2022 11:42am

https://www.investing.com/news/pro/nuvasive-pt-lowered-to-58-at-rbc-capital-432SI-2939640


Source:Investing.com
NuVasive, Inc. (NUVA) Q3 2022 - Earnings Call Transcript
Nov 10, 2022 02:52am

NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q3 2022 Earnings Conference Call November 09, 2022, 04:30 PM ET Company Participants Juliet Cunningham - Vice President-Investor Relations Chris Barry -…


Source:Seeking Alpha
NuVasive, Inc. Q3 Earnings Summary
Nov 09, 2022 21:28pm

WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: -$1.98 million in Q3 vs. -$21.64 million in the same period last year. EPS: -$0.04 in Q3 vs. -$0.42 in …


Source:Finanz Nachrichten
NuVasive reports Q3 mixed earnings; updates FY22 guidance
Nov 09, 2022 21:22pm

NuVasive press release (NUVA): Q3 Non-GAAP EPS of $0.54 in-line.Revenue of $295.3M (+9.0% Y/Y) misses by $3.46M.Non-GAAP gross margin was 72.6%, compared to 72.7% in the prior…


Source:Seeking Alpha
NuVasive Announces Third Quarter 2022 Financial Results
Nov 09, 2022 21:05pm

– Net sales grew 9.0% as reported, 12.9% on a constant currency basis – – C360 portfolio delivers record quarter in cervical net sales – – Company updates full-year 2022 guidance – SAN DIEGO, Nov. 9, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology…


Source:PR Newswire
NuVasive Launches Tube System and Excavation Micro for Posterior Spine Surgery
Nov 07, 2022 12:00pm

SAN DIEGO, Nov. 7, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the commercial launch of the NuVasive Tube System (NTS) and…


Source:PR Newswire
NuVasive: Prepared To Endure Current Headwinds (NASDAQ:NUVA)
Nov 01, 2022 12:37pm

NuVasive managed to grow sales over the years until it experienced lower elective procedure volumes due to COVID-19 pandemic. Read why NUVA is a good opportunity for patient investors.


Source:Seeking Alpha
NuVasive Announces Conference Call and Webcast of Third Quarter 2022 Results
Oct 25, 2022 11:00am

SAN DIEGO, Oct. 25, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter financial…


Source:PR Newswire
NuVasive PT Lowered to $51 at Truist Securities
Oct 17, 2022 12:13pm

https://www.investing.com/news/pro/nuvasive-pt-lowered-to-51-at-truist-securities-432SI-2913771


Source:Investing.com
Jefferies Starts NuVasive at Hold
Oct 11, 2022 21:15pm

https://www.investing.com/news/pro/jefferies-starts-nuvasive-at-hold-432SI-2909932


Source:Investing.com
NuVasive PT Lowered to $48 at Morgan Stanley
Oct 07, 2022 12:37pm

https://www.investing.com/news/pro/nuvasive-pt-lowered-to-48-at-morgan-stanley-432SI-2907365


Source:Investing.com
NuVasive PT Lowered to $53 at Needham & Company
Sep 30, 2022 11:48am

https://www.investing.com/news/pro/nuvasive-pt-lowered-to-53-at-needham--company-432SI-2902871


Source:Investing.com